More than 13,500 people contracted COVID-19 in Connecticut between Aug. 1 and Oct. 5, according to the most recent state data ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

Innovative whole system approaches to integrate research and novel technologies within patient pathways are needed to target antibiotic use, minimise healthcare associated infections, and adapt to ...

New data published yesterday in Morbidity and Mortality Weekly Report (MMWR) show older adults continue to be hospitalized ...

Sep. 30, 2024 — To help speed decarbonization, state regulators should reconceive of gas and electric utilities as serving the same purpose, according to a new report. Without coordinated action ...

Oct. 2, 2024 — Researchers have developed a solid electrolyte that could be a suitable material for all-solid-state batteries. Solid electrolyte composed of nanoparticles embedded in an ...

Through COVIDTests.gov, you can order up to four free COVID-19 tests per household, shipped at no cost to you. No payment or ...

The FDA has revised the EUA for Pemgarda (pemivibart), authorized for the preexposure prophylaxis of COVID-19.

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after you’ve ...